$AMS

Stachowiak Raymond C purchased $1.3M of AMS (indirect holdings)

Stachowiak Raymond C (Executive Chairman) purchased 586,468 indirectly-held shares of AMERICAN SHARED HOSPITAL SERVICES (AMS) at $2.28 ($1.34M total) on 2026-06-22.

Original reporting
SEC EDGAR · Stachowiak Raymond C
Published Jun 24, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 6:50 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AMS
Bullish
low confidence
Mentioned
$AMS
Relevance
7/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AMSBullishLow
01

Why it matters

The newest fact is the reported open-market purchase amount, share count, and price, which may influence short-term sentiment but does not change fundamentals by itself.

02

Market read

Traders may note the insider buy as a small sentiment input, but there is no guidance, contract, or operational update in the filing text.

03

What to watch

The article provides no context on why the purchase occurred, whether it was part of a broader pattern, or any concurrent company-specific developments.

Relevance 7/10Novelty 5/10Timing: Filed 2026-06-24, transaction dated 2026-06-22.

Background

The article is an SEC Form 4 insider transaction disclosure for American Shared Hospital Services (AMS).

Company-level read

Ticker impact

$AMSBullishLow confidence
Context

SEC Form 4 shows Stachowiak Raymond C, Executive Chairman, bought $1.34M of AMS shares on 2026-06-22 at $2.2800.

Expected impact

Likely limited near-term impact; any effect is sentiment-driven and may fade without follow-on company news.

Evidence & confidence

The filing is a Form 4 insider transaction with no 10b5-1 plan and no accompanying operational or financial disclosure in the text.

Market effects

No sector-level implications are disclosed; this is company-specific insider activity.

None indicated.

None indicated.

Counterpoint

Insider purchases can be routine liquidity or diversification moves and may not reflect near-term business improvement.

Key entities

  • American Shared Hospital Services

    Subject of the Form 4 insider transaction disclosure.

  • Stachowiak Raymond C

    Executive Chairman and reporting person who purchased shares indirectly.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AMSMed

American Shared Hospital Services Q2 Net Loss Widens to $514,000 Despite Revenue Growth – Minichart

American Shared Hospital Services (NYSE American: AMS) reported a Q2 2026 net loss of $514,000, or $0.07 per diluted share, widening from a $280,000 loss a year earlier, despite revenue rising 19.2% to $8.43 million. Direct patient services drove growth, while gross profit and operating loss worsened. Cash rose to $6.511 million at June 30, 2026, and the company later arranged financing with Fifth Third Bank.

$AMSMed

American Shared Hospital Services (AMS) (Q2 2026) Earnings Call Highlights: Strong

American Shared Hospital Services (AMS) reported Q2 2026 earnings call highlights including 19% year-over-year revenue growth driven by direct patient services, higher international Gamma Knife volumes, and improving proton beam performance. Proton beam revenue rose 22% to about $2.3M in the quarter and $4.3M for six months. Reported results were impacted by $285k legal costs and a $909k credit-loss allowance. Cash equivalents and restricted cash were about $6.8M.

$AMSHighAI 8/10

American Shared Hospital (NYSE: AMS) grows revenue while warning on going concern

American Shared Hospital Services (NYSE: AMS) reported Q2 2026 revenue of $8.43M and $15.51M for the first half, up from $7.07M and $13.18M a year earlier, driven by direct patient services and higher PBRT and Gamma Knife volumes. The company posted net losses of $0.51M in Q2 and $1.13M for six months and disclosed substantial doubt about its going concern due to covenant breaches and debt default notices.

$AMSMedAI 8/10

Earnings call transcript: American Shared Hospital Services posts Q2 2026 revenue beat

American Shared Hospital Services reported Q2 2026 revenue of $8.4 million, up 19.2% year over year and above the $7.56 million forecast. Adjusted EPS was a loss of $0.07 versus an expected loss of $0.02. Direct patient services rose to $4.9 million and proton beam revenue to about $2.3 million. Cash and equivalents were $6.8 million; management discussed refinancing debt due in 2027.

$AMSMed

American Shared Hospital Q2 Results: Revenue up 19% to $8.4 million

American Shared Hospital Services (AMEX: AMS) reported Q2 2026 revenue of $8.4 million, up 19% year over year. Direct patient services rose about 40% to $4.9 million, while Proton Beam Radiation Therapy revenue increased 22% to about $2.3 million. Adjusted EBITDA fell to about $1.3 million from $1.7 million. Cash increased to $6.8 million by quarter end.

$AMSMedAI 8/10

American Shared Hospital Q2 2026 Earnings Call Transcript - American Shared Hospital (AMEX:AMS)

American Shared Hospital Services (AMEX:AMS) held its Q2 2026 earnings call. The company reported Q2 revenue of about $8.4 million, up 19% year over year, and first-half revenue up 18% to over $15.5 million. It cited higher patient volumes, Proton Beam activity, and international operations. First-half operating cash was $4.4 million and cash rose over 80% to $6.8 million, despite a $909,000 credit-loss charge.